In breathless press releases and posts, the company has touted its models’ ability to deliver scientific breakthroughs. But its IPO filing taps the brakes on just how fast its AI will lead to big discoveries.

The new open-source model speaks the language of DNA and can help researchers understand the effects of any changes on gene activity and health.

It’s the latest in a growing wave of bets that AI companies are making on brain data.